PHSA - 19193 Chronic Pain Management Dorsal Root Ganglion
The Dorsal Root Ganglion (DRG) therapy is required to treat specific chronic conditions such as complex regional painsyndrome (CRPS) and other focal neuropathic pain syndromes that are not effectively managed with traditional spinal cordstimulation (SCS). DRG enables highly targeted stimulation at t...
Actions
Create a free account to analyze this opportunity, get daily notifications, and win more bids with Narwin.ai
Documents
No documents are currently available in Narwin.
Visit original source to check related documentsDescription
Read full description
The Dorsal Root Ganglion (DRG) therapy is required to treat specific chronic conditions such as complex regional painsyndrome (CRPS) and other focal neuropathic pain syndromes that are not effectively managed with traditional spinal cordstimulation (SCS). DRG enables highly targeted stimulation at the dorsal root ganglion for precise pain coverage, reducedpositional variability, and improved outcomes in select patients.The DRG therapy provides clinicians with enhanced programming capabilities to tailor treatment to individual patient needs.
Additional Information
Source
canadabuys
Type
RFP
Status
open
Reference Number
bcphsa-19193
Contact Email
Last Updated
October 14, 2026
Frequently Asked Questions
When is the proposal submission deadline?
The proposal submission deadline is October 23, 2026 (9 days left).
Where can I submit a proposal or get solicitation documents?
You can access the full solicitation documents and submit your proposal at the official source:
Visit Official SourceNarwin.ai is a great way to find government contracts and opportunities. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.